ALS drug wins FDA approval despite questionable data

almost 3 years in Jamaica Gleaner

WASHINGTON, DC (AP) — A much-debated drug for Lou Gehrig's disease won US approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines. The...

Mentioned in this news
Share it on